Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What specific challenges caused apotex's ruxolitinib's fda approval delay?How does alcohol affect the effectiveness of lyrica?What liver issues can lipitor reveal?Should lipitor dosage be reduced with vitamin e use?How long does nivolumab's immune boost last?
See the DrugPatentWatch profile for simponi
Yes. Simponi is a biologic medicine. Its active ingredient, golimumab, is a tumor necrosis factor (TNF) blocker made using biologic manufacturing processes typical of monoclonal antibodies. [1]
Biologics are large, complex molecules made from living cells, and they’re often delivered by injection (Simponi is given by subcutaneous injection or infusion depending on the formulation). By contrast, many standard “small-molecule” drugs are chemically synthesized pills. [1]
No. Simponi is an originator brand-name biologic (golimumab), not a biosimilar. [1] Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Simponi :